Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Acq. announced
|
|
Pulmatrix, Inc. (PULM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/13/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 07/11/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 06/02/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 06/02/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/12/2023 |
8-K
| Quarterly results |
| 03/30/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/30/2023 |
8-K
| Quarterly results |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 2.7% stake in Pulmatrix, Inc. |
| 02/06/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/03/2023 |
8-K
| Quarterly results |
| 01/30/2023 |
4
| Siegert Michelle (Vice President, Finance) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 9,900 options to buy
@ $3.99, valued at
$39.5k
|
|
| 01/30/2023 |
4
| Wasilewski Margaret (Chief Medical Officer) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 11,400 options to buy
@ $3.99, valued at
$45.5k
|
|
| 01/30/2023 |
4
| Raad Teofilo David (CEO) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 34,900 options to buy
@ $3.99, valued at
$139.3k
|
|
| 01/30/2023 |
4
| Bazemore Todd (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 1,700 options to buy
@ $3.99, valued at
$6.8k
|
|
| 01/30/2023 |
4
| Higgins Michael J (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 2,436 options to buy
@ $3.99, valued at
$9.7k
|
|
| 01/30/2023 |
4
| Cabell Christopher (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 1,700 options to buy
@ $3.99, valued at
$6.8k
|
|
| 01/30/2023 |
4
| Varadan Anand (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 1,700 options to buy
@ $3.99, valued at
$6.8k
|
|
| 01/30/2023 |
4
| Batycky Richard P. (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 1,700 options to buy
@ $3.99, valued at
$6.8k
|
|
| 01/25/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 01/11/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 8.3% stake in Pulmatrix, Inc. |
| 01/04/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/26/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/10/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/10/2022 |
8-K
| Quarterly results |
| 08/09/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/12/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/12/2022 |
8-K
| Quarterly results |
| 05/02/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|
|
|